Drug Shortage Report for VISKAZIDE
| Report ID | 151235 |
| Drug Identification Number | 00568635 |
| Brand name | VISKAZIDE |
| Common or Proper name | HYDROCHLOROTHIAZIDE PINDOLOL |
| Company Name | XEDITON PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE PINDOLOL |
| Strength(s) | 50MG 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 3x35 Tablets |
| ATC code | C07CA |
| ATC description | BETA BLOCKING AGENTS AND OTHER DIURETICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-12-20 |
| Actual start date | |
| Estimated end date | 2022-01-31 |
| Actual end date | 2022-04-13 |
| Shortage status | Resolved |
| Updated date | 2022-04-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2020 WINSTON PARK DRIVE OAKVILLE, ONTARIO CANADA L6H 6X7 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-04-27 | French | Compare |
| v4 | 2022-04-27 | English | Compare |
| v3 | 2021-12-21 | English | Compare |
| v2 | 2021-12-15 | French | Compare |
| v1 | 2021-12-15 | English | Compare |
Showing 1 to 5 of 5